Literature DB >> 8926110

Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes.

E Mattsson1, H Van Dijk, J Verhoef, R Norrby, J Rollof.   

Abstract

Bacterial products from gram-positive bacteria, such as peptidoglycan, teichoic acid, and toxins, activate mononuclear cells to produce tumor necrosis factor alpha (TNF). The present study evaluated the release of soluble cell wall components from Staphylococcus epidermidis capable of inducing TNF after exposure of the bacteria to various antibiotics. A clinical S. epidermidis isolate (694) was incubated with either penicillin, oxacillin, vancomycin, or clindamycin at five times the MIC. Supernatants of the cultures obtained by filtration were added to plastic adherent monocytes in the absence or presence of human serum. After 18 h of incubation, monocyte supernatants were tested for the presence of TNF by enzyme-linked immunosorbent assay (ELISA). Supernatants from bacteria incubated with beta-lactam antibiotics induced higher TNF levels than those obtained from bacteria incubated with culture medium only (no antibiotics), vancomycin, or clindamycin. Human serum potentiated supernatant-induced TNF release, especially in beta-lactam supernatants. The soluble peptidoglycan and teichoic acid contents of supernatants, as estimated by inhibition ELISA and, for peptidoglycan, also by affinity depletion with vancomycin-Sepharose gel, were proportional to TNF release. Differences in the ability of individual antibiotics to generate TNF-releasing products from S. epidermidis were observed, the most potent antibiotics being penicillin and oxacillin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926110      PMCID: PMC174378          DOI: 10.1128/iai.64.10.4351-4355.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Penicillin-induced secretion of soluble, uncross-linked peptidoglycan by Micrococcus luteus cells.

Authors:  D Mirelman; R Bracha; N Sharon
Journal:  Biochemistry       Date:  1974-11-19       Impact factor: 3.162

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Toxinogenicity of clinical isolates of coagulase-negative staphylococci towards various animal cells.

Authors:  C G Gemmell; M Thelestam
Journal:  Acta Pathol Microbiol Scand B       Date:  1981-12

4.  Oxacillin-induced lysis of Staphylococcus aureus.

Authors:  R H Raynor; D F Scott; G K Best
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  Endotoxin-like properties of the peptidoglycan.

Authors:  J Rotta
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

6.  Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes.

Authors:  S Bhakdi; M Muhly; S Korom; F Hugo
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

7.  Antibody response to peptidoglycan during staphylococcal infections.

Authors:  L J Wheat; B J Wilkinson; R B Kohler; A C White
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

8.  The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; S D Douglas; P G Quie; J Verhoef
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus.

Authors:  A R Zeiger; C U Tuazon; J N Sheagren
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus.

Authors:  A R Zeiger; W Wong; A N Chatterjee; F E Young; C U Tuazon
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more
  8 in total

1.  Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis.

Authors:  M H Veltrop; J A Langermans; J Thompson; M J Bancsi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.

Authors:  G J Merkel; B A Scofield
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 3.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 4.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 5.  Linezolid effects on bacterial toxin production and host immune response: review of the evidence.

Authors:  Binh An Diep; Ozlem Equils; David B Huang; Ron Gladue
Journal:  Curr Ther Res Clin Exp       Date:  2012-06

6.  Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus.

Authors:  Meng-Meng Shi; Antoine Monsel; Jean-Jacques Rouby; Yan-Ping Xu; Ying-Gang Zhu; Jie-Ming Qu
Journal:  Front Microbiol       Date:  2019-10-04       Impact factor: 5.640

7.  Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities.

Authors:  P van Langevelde; J T van Dissel; E Ravensbergen; B J Appelmelk; I A Schrijver; P H Groeneveld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

8.  Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm (Lond)       Date:  2016-11-28       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.